JASON HOHMAN: Open Payments
NPI 1093409880 · FLORISSANT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 45 payments from 9 companies in 2025. Trend: 2023 $187 · 2024 $636 · 2025 $744
Food & beverage: $744
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 26 | $377 |
| ABBVIE INC. | 8 | $162 |
| PFIZER INC. | 3 | $47 |
| PROTEGA PHARMACEUTIALS INC | 2 | $46 |
| IBSA Pharma Inc. | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Valinor Pharma, LLC | 1 | $18 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
| Tonix Medicines, Inc. | 1 | $18 |
Products named: RELISTOR, QULIPTA, UBRELVY, NURTEC ODT, ROXYBOND, Tirosint, Symbravo, MOVANTIK.
Industry payments across MO — which companies pay providers there.
